RECRUITING

Monoferric for Prenatal Iron Deficiency

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.

Official Title

Monoferric for Prenatal Iron Deficiency

Quick Facts

Study Start:2024-01-18

Study Completion:2028-10

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05763043

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Participants 18 years of age or older between 14 to 42 weeks gestation who are deemed appropriate for IV iron by their treating provider as part of their standard of care treatment. * Iron deficiency anemia, defined as second or third trimester (14 weeks or more) hemoglobin less than or equal to 10.5 g/dL or less than or equal to11 g/dL, respectively, and ferritin less than 50 μg/L * Experience intolerance to oral iron or are greater than 28 weeks gestation * Willing to participate in the study	* Known infectious, inflammatory, or malignant conditions that may confound iron repletion and outcome analysis * Prior IV iron intolerance or hypersensitivity reaction

Inclusion Criteria

Exclusion Criteria

* Participants 18 years of age or older between 14 to 42 weeks gestation who are deemed appropriate for IV iron by their treating provider as part of their standard of care treatment.
* Iron deficiency anemia, defined as second or third trimester (14 weeks or more) hemoglobin less than or equal to 10.5 g/dL or less than or equal to11 g/dL, respectively, and ferritin less than 50 μg/L
* Experience intolerance to oral iron or are greater than 28 weeks gestation
* Willing to participate in the study

* Known infectious, inflammatory, or malignant conditions that may confound iron repletion and outcome analysis
* Prior IV iron intolerance or hypersensitivity reaction

Contacts and Locations

Study Contact

Women's Health Research Unit Research Unit Department of OB/Gyn

CONTACT

503-494-3666

whru@ohsu.edu

Study Locations (Sites)

Oregon Health & Science Univerity

Portland, Oregon, 97239

United States

Collaborators and Investigators

Sponsor: Oregon Health and Science University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-18

Study Completion Date2028-10

Study Record Updates

Study Start Date2024-01-18

Study Completion Date2028-10

Terms related to this study

Additional Relevant MeSH Terms

Obstetric Labor Complications